ArticleNPJ digital medicine2026
Machine learning-guided Huanglian Jiedu decoction targets STING in periodontitis-induced Alzheimer's Disease.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder increasingly associated with peripheral inflammatory conditions such as chronic periodontitis (CP); however, the molecular mechanisms linking these conditions remain poorly understood. Here, we investigated the therapeutic effects of Huanglian Jieddu Decoction (HLJDD) on CP-induced AD using an integrative machine learning-guided multi-omics approach. Analysis of public single-cell RNA-sequencing data revealed pronounced inflammatory activation in microglia from AD samples. We further established a CP-induced AD rat model and performed hippocampal transcriptomic profiling. Multiple complementary machine learning strategies, including Random Forest-based feature selection, support vector machine-based refinement, network modeling, and interpretable model analysis, were applied to prioritize disease-relevant pathways from high-dimensional transcriptomic data. Across models, components of the cGAS-STING signaling pathway consistently exhibited strong and directional contributions to CP-AD pathology, indicating a central inflammatory axis linking peripheral infection to neurodegeneration. Guided by these data-driven insights, in vivo and in vitro experiments demonstrated that HLJDD suppressed cGAS-STING activation, attenuated neuroinflammation, and improved cognitive function in CP-induced AD models. Collectively, this study highlights the value of machine learning-assisted transcriptomic interpretation for mechanistic prioritization and identifies HLJDD as a multitarget therapeutic strategy for CP-induced AD.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.